Source link : https://newshealth.biz/health-news/fda-gives-broad-approval-to-gene-therapy-for-rare-neurologic-disease/
(MedPage Today) — The FDA approved the intrathecal gene therapy onasemnogene abeparvovec (Itvisma) to treat spinal muscular atrophy (SMA) in adults and pediatric patients 2 years and older with a confirmed mutation in the survival motor neuron… Source link : https://www.medpagetoday.com/neurology/generalneurology/118708 Author : Publish date : 2025-11-25 17:34:00 Copyright for syndicated content belongs to the […]
The post FDA Gives Broad Approval to Gene Therapy for Rare Neurologic Disease first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-25 17:34:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8